Eremid Genomic Services is a dynamic player in the Biotechnology sector, founded in 2019 and headquartered in the United States. The company positions itself as a bespoke partner for research programs across Human Health, Food & Nutrition, and AgBiotech industries, emphasizing customized contract research programs.
With its slogan, "Successfully advancing your research," Eremid highlights its commitment to providing expert consultancy, efficient timelines, and regular updates until projects' completion. The company underscores its use of cutting-edge instrumentation to deliver tailored, multi-platform solutions, crucial from concept to data delivery.
The latest financial milestone saw a $3.00M venture round investment secured on June 26, 2023, led by Coddle Creek Capital. This investment underlines confidence in Eremid's capabilities and growth potential in the genomics space.